Jv. Selby et al., First 20 months' experience with use of metformin for type 2 diabetes in alarge health maintenance organization, DIABET CARE, 22(1), 1999, pp. 38-44
OBJECTIVE - To assess adherence to prescribing guidelines, continuation rat
es, population effects on glycemic control, and occurrence of lactic acidos
is during the first 20 months of the availability of metformin in a large h
ealth maintenance organization.
RESEARCH DESIGN AND METHODS - A retrospective cohort study was performed in
the 90,000-member diabetes registry of Kaiser Permanente, northern Califor
nia. Principal study measures were the proportions of patients started on m
etformin who met prescribing guidelines (previously on sulfonylureas, HbA(1
c) obesity, creatinine), the change in HbA(1c), at 6 months after starting
metformin, and hospitalization rates for lactic acidosis.
RESULTS - A total of 9,875 patients received metformin during this interval
. At least 74% were previously treated with sulfonylureas alone, 81% had ba
seline HbA(1c) greater than or equal to 8.5%, 71% were obese, and 99% had a
serum creatinine less than or equal to 1.5 mg/dl. Among patients on sulfon
ylureas at baseline, those starting metformin had significantly lower HbA(1
c) levels 6 months later than those not started, alter adjustment for age,
sex, and the higher baseline levels in those started (adjusted difference:
0.5%, P < 0.0001). Patients starting metformin as initial monotherapy also
improved significantly, but patients previously treated with insulin (with
or without sulfonylureas) had slightly higher follow-up HbA(1c) levels than
similar patients not starting metformin. Continuation of metformin at 12 m
onths was significantly higher for patients previously treated with sulfony
lureas than other groups. One probable case of lactic acidosis was identifi
ed during 4,502 person-years on metformin.
CONCLUSIONS - Adherence to prescribing guidelines was relatively high durin
g metformin's first 20 months of availability. Glycemic control improved su
bstantially for patients previously treated with sulfonylureas. Lactic acid
osis was rare.